Please disable your adblock and script blockers to view this page

New study suggests Johnson & Johnson less effective against variants | TheHill


The Johnson & Johnson COVID-19
bioRxiv
Pfizer-BioNTech or Moderna
the Johnson & Johnson
NYU
Grossman School of Medicine
The New York Times
J&J
Pfizer or Moderna
Weill Cornell Medicine
SponsoredThe
NW Suite 900 Washington DC
Capitol Hill Publishing Corp.
News Communications


Nathaniel Landau
John Moore
Paul Stoffels


mRNA

No matching tags


the Johnson & Johnson
1625 K Street


New York
Inc.

No matching tags

Positivity     42.00%   
   Negativity   58.00%
The New York Times
SOURCE: http://thehill.com/homenews/563991-new-study-finds-johnson-johnson-less-effective-against-variants
Write a review: The Hill
Summary

The Johnson & Johnson COVID-19 vaccine may be less effective in battling coronavirus variants...

As said here by Sarah Polus